Influence of estrogen plus progestin on breast cancer and mammography in healthy postmenopausal women: the Women's Health Initiative Randomized Trial
…, MA Gilligan, MG Cyr, CA Thomson, J Khandekar… - Jama, 2003 - jamanetwork.com
ContextThe Women's Health Initiative trial of combined estrogen plus progestin was
stopped early when overall health risks, including invasive breast cancer, exceeded benefits. …
stopped early when overall health risks, including invasive breast cancer, exceeded benefits. …
[HTML][HTML] Association of sickle cell trait with risk and mortality of COVID-19: results from the United Kingdom Biobank
…, C Struve, BT Helfand, J Khandekar… - The American Journal …, 2021 - ncbi.nlm.nih.gov
Sickle cell trait (SCT) carriers inherit one copy of the Glu6Val mutation in the hemoglobin
gene and is particularly common in Black individuals (5–10%). Considering the roles of …
gene and is particularly common in Black individuals (5–10%). Considering the roles of …
A phase III randomized prospective trial of external beam radiotherapy, mitomycin C, carmustine, and 6-mercaptopurine for the treatment of adults with anaplastic …
…, T Byrne, M Salter, J Imperato, J Khandekar… - International Journal of …, 1996 - Elsevier
By the late 1970s clinical trials had established that the median survival of adults with
supratentorial malignant gliomas, treated with surgery, external beam radiotherapy (ERT), and …
supratentorial malignant gliomas, treated with surgery, external beam radiotherapy (ERT), and …
Germline mutations in ATM and BRCA1/2 distinguish risk for lethal and indolent prostate cancer and are associated with early age at death
…, Y Wu, X Liu, N Zhang, CH Wang, J Khandekar… - European urology, 2017 - Elsevier
Background Germline mutations in BRCA1/2 and ATM have been associated with prostate
cancer (PCa) risk. Objective To directly assess whether germline mutations in these three …
cancer (PCa) risk. Objective To directly assess whether germline mutations in these three …
Low-fat dietary pattern and cancer incidence in the Women's Health Initiative Dietary Modification Randomized Controlled Trial
…, S Yasmeen, B Singh, J Khandekar… - Journal of the …, 2007 - academic.oup.com
Background The Women's Health Initiative Dietary Modification (DM) Randomized Controlled
Trial evaluated the effects of a low-fat dietary pattern on chronic disease incidence, with …
Trial evaluated the effects of a low-fat dietary pattern on chronic disease incidence, with …
Prospective analysis of association between use of statins or other lipid-lowering agents and colorectal cancer risk
…, HK Roy, DS Lane, JA Cauley, J Khandekar - Annals of …, 2012 - Elsevier
PURPOSE: To determine whether 3-hydroxy-3-methylglutaryl coenzyme A inhibitors (statins)
are associated with a decreased risk of colorectal cancer. METHODS: The population …
are associated with a decreased risk of colorectal cancer. METHODS: The population …
Dietary omega-3 polyunsaturated fatty acids suppress expression of EZH2 in breast cancer cells
…, PV Bommi, AA Sahasrabuddhe, JD Khandekar… - …, 2010 - academic.oup.com
The polycomb group (PcG) protein, enhancer of zeste homologue 2 (EZH2), is overexpressed
in several human malignancies including breast cancer. Aberrant expression of EZH2 has …
in several human malignancies including breast cancer. Aberrant expression of EZH2 has …
Implementation of a multidisciplinary pharmacogenomics clinic in a community health system
…, SG Johnson, PJ Hulick, J Khandekar - American Journal of …, 2016 - academic.oup.com
Purpose The development and implementation of a multidisciplinary pharmacogenomics
clinic within the framework of an established community-based medical genetics program are …
clinic within the framework of an established community-based medical genetics program are …
Chemotherapy of brain tumors: The blood-brain barrier is not a factor
NA Vick, JD Khandekar, DD Bigner - Archives of Neurology, 1977 - jamanetwork.com
Brain tumors are not rare. In the United States, nearly 11,000 new patients were seen in
1976. This number can be expected to increase as systemic cancers are controlled more …
1976. This number can be expected to increase as systemic cancers are controlled more …
Changes in performance after implementation of a multifaceted electronic-health-record-based quality improvement system
…, NC Dolan, B Andrews, S Levi, J Khandekar… - Medical care, 2011 - journals.lww.com
Background: Electronic health record (EHR) systems have the potential to revolutionize
quality improvement (QI) methods by enhancing quality measurement and integrating multiple …
quality improvement (QI) methods by enhancing quality measurement and integrating multiple …